Eikon Therapeutics (EIKN) vs TRex Bio (TRXB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 12, 2026.
Summary
Eikon Therapeutics is the larger company by market cap ($393.2 million vs $385.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | EIKN | TRXB |
|---|---|---|
| Share price | $7.26 | $14.03 |
| Market cap | $393.24M | $385.06M |
| 1-day change | -2.81% | +0.21% |
| EPS (TTM) | $-8.51 | $-2.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.40 | $15.50 |
| 52-week low | $7.02 | $13.50 |
| Distance from 52-week high | -58.28% | -9.48% |
| Analyst consensus | none | — |
| Avg. price target upside | +238.84% | — |
| Average volume | 497.87K | 1.26M |
| Shares outstanding | 54.17M | 27.45M |
| Employees | 384 | 60 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Eikon Therapeutics
EIKN stock →Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 384 employees
About TRex Bio
TRXB stock →TRex Bio, Inc. operates as a clinical-stage biopharmaceutical company that engages in discovery and development of immunoregulatory medicines.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 60 employees
EIKN vs TRXB FAQ
Which is bigger, Eikon Therapeutics or TRex Bio?
Eikon Therapeutics (EIKN) is larger, with a market capitalization of $393.24M compared with $385.06M for TRex Bio (TRXB).
Are Eikon Therapeutics and TRex Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.